Journal
ORAL ONCOLOGY
Volume 87, Issue -, Pages 204-206Publisher
ELSEVIER SCIENCE BV
DOI: 10.1016/j.oraloncology.2018.10.019
Keywords
Nasopharyngeal cancer; PDL1; Nivolumab; Radiotherapy; First-line; Oligometastatic disease; Platinum-induced neurotoxicity